Effect of modified Yiqi Huoxue therapy on patients with heart failure with preserved ejection fractio
Not Applicable
Completed
- Conditions
- Heart Failure with preserved Ejection Fraction,HFpEF
- Registration Number
- ITMCTR2100004908
- Lead Sponsor
- Beijing Hepingli Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The diagnosis of HFPEF was based on the 2018 Guidelines for the Diagnosis and Treatment of Chronic Heart Failure in China. Main diagnostic criteria:
1. Symptoms: dyspnea, fatigue, edema of lower limbs;
2. Signs: rales in the lungs, tachypnea, swollen jugular vein, enlarged liver;
3. Auxiliary examination: echocardiography revealed enlarged heart, abnormal cardiac function, and elevated plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP). However, the Left Ventricle Eject Fraction (LVEF) >= 50%.
Exclusion Criteria
Patients with hyperthyroidism, renal disease, tumor, recent urinary tract infection, short-term systemic infection, and pregnancy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 6 Minute Walk Distance, 6MWD;Left Atrial Diameter, LAD;heart rate;E/A;blood pressure;Left Ventricular End-diastolic Dimension, LVEDD;
- Secondary Outcome Measures
Name Time Method